Vertex Ev To Free Cash Flow vs Free Cash Flow Analysis

VRTX Stock  USD 465.73  2.40  0.51%   
Vertex Pharmaceuticals financial indicator trend analysis is much more than just breaking down Vertex Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vertex Pharmaceuticals is a good investment. Please check the relationship between Vertex Pharmaceuticals Ev To Free Cash Flow and its Free Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

Ev To Free Cash Flow vs Free Cash Flow

Ev To Free Cash Flow vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vertex Pharmaceuticals Ev To Free Cash Flow account and Free Cash Flow. At this time, the significance of the direction appears to have very week relationship.
The correlation between Vertex Pharmaceuticals' Ev To Free Cash Flow and Free Cash Flow is 0.22. Overlapping area represents the amount of variation of Ev To Free Cash Flow that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Vertex Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Vertex Pharmaceuticals' Ev To Free Cash Flow and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Free Cash Flow of Vertex Pharmaceuticals are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Ev To Free Cash Flow i.e., Vertex Pharmaceuticals' Ev To Free Cash Flow and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.22
Relationship DirectionPositive 
Relationship StrengthVery Weak

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from Vertex Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 798.2 M in 2024, whereas Discontinued Operations is likely to drop (861.8 K) in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit6.7B7.9B8.6B9.0B
Total Revenue7.6B8.9B9.9B10.4B

Vertex Pharmaceuticals fundamental ratios Correlations

0.290.960.981.00.88-0.980.940.990.990.890.990.210.580.620.590.991.0-0.070.980.940.990.360.370.860.04
0.290.240.310.260.52-0.170.050.230.330.110.260.620.690.190.650.420.270.340.380.340.240.710.710.150.6
0.960.240.980.960.81-0.940.940.950.950.860.950.130.490.670.480.940.96-0.080.950.920.960.290.30.780.05
0.980.310.980.980.84-0.940.940.950.980.840.960.170.510.690.540.970.97-0.060.970.910.970.330.340.820.03
1.00.260.960.980.88-0.980.950.990.990.890.990.180.550.610.570.981.0-0.080.970.940.990.340.350.870.01
0.880.520.810.840.88-0.830.720.860.880.760.880.460.790.330.80.910.88-0.070.860.910.860.610.610.750.26
-0.98-0.17-0.94-0.94-0.98-0.83-0.94-1.0-0.94-0.96-0.99-0.2-0.55-0.61-0.54-0.96-0.990.1-0.95-0.94-0.99-0.33-0.34-0.840.0
0.940.050.940.940.950.72-0.940.940.930.840.93-0.10.340.630.290.890.94-0.070.930.880.930.060.070.79-0.14
0.990.230.950.950.990.86-1.00.940.960.951.00.210.580.610.570.971.0-0.080.960.950.990.350.360.840.02
0.990.330.950.980.990.88-0.940.930.960.830.960.190.540.60.590.980.97-0.050.960.910.970.360.370.880.04
0.890.110.860.840.890.76-0.960.840.950.830.940.270.580.580.540.880.92-0.110.860.90.940.350.360.750.03
0.990.260.950.960.990.88-0.990.931.00.960.940.230.60.610.590.981.0-0.10.970.950.990.370.380.850.04
0.210.620.130.170.180.46-0.2-0.10.210.190.270.230.650.10.820.30.220.00.20.270.230.970.970.230.6
0.580.690.490.510.550.79-0.550.340.580.540.580.60.650.060.790.670.590.00.610.660.570.720.730.390.53
0.620.190.670.690.610.33-0.610.630.610.60.580.610.10.060.220.620.620.20.630.540.640.180.180.48-0.18
0.590.650.480.540.570.8-0.540.290.570.590.540.590.820.790.220.660.58-0.080.550.580.590.870.880.590.41
0.990.420.940.970.980.91-0.960.890.970.980.880.980.30.670.620.660.99-0.020.980.940.980.460.470.830.12
1.00.270.960.971.00.88-0.990.941.00.970.921.00.220.590.620.580.99-0.080.980.950.990.360.370.850.03
-0.070.34-0.08-0.06-0.08-0.070.1-0.07-0.08-0.05-0.11-0.10.00.00.2-0.08-0.02-0.080.020.07-0.070.020.02-0.07-0.13
0.980.380.950.970.970.86-0.950.930.960.960.860.970.20.610.630.550.980.980.020.940.960.370.380.810.1
0.940.340.920.910.940.91-0.940.880.950.910.90.950.270.660.540.580.940.950.070.940.950.40.410.780.11
0.990.240.960.970.990.86-0.990.930.990.970.940.990.230.570.640.590.980.99-0.070.960.950.360.370.860.02
0.360.710.290.330.340.61-0.330.060.350.360.350.370.970.720.180.870.460.360.020.370.40.361.00.340.61
0.370.710.30.340.350.61-0.340.070.360.370.360.380.970.730.180.880.470.370.020.380.410.371.00.350.6
0.860.150.780.820.870.75-0.840.790.840.880.750.850.230.390.480.590.830.85-0.070.810.780.860.340.350.01
0.040.60.050.030.010.260.0-0.140.020.040.030.040.60.53-0.180.410.120.03-0.130.10.110.020.610.60.01
Click cells to compare fundamentals

Vertex Pharmaceuticals Account Relationship Matchups

Vertex Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets8.3B11.8B13.4B18.2B22.7B23.9B
Short Long Term Debt Total577.4M581.5M556.7M561M808.4M848.8M
Other Current Liab1.0B1.1B1.7B2.2B2.8B3.0B
Total Current Liabilities1.2B1.6B1.9B2.4B3.5B3.7B
Total Stockholder Equity6.1B8.7B10.1B13.9B17.6B18.5B
Property Plant And Equipment Net745.1M958.5M1.1B1.1B1.5B1.5B
Net Debt(2.5B)(5.4B)(6.2B)(9.9B)(9.6B)(9.1B)
Retained Earnings(1.9B)858.7M3.2B6.5B10.1B10.6B
Cash3.1B6.0B6.8B10.5B10.4B10.9B
Non Current Assets Total3.7B3.9B4.4B5.5B8.6B9.0B
Non Currrent Assets Other326.9M662.5M901.1M1.3B796.7M836.5M
Cash And Short Term Investments3.8B6.7B7.5B10.8B11.2B11.8B
Common Stock Shares Outstanding260.7M263.4M259.9M259.1M260.5M153.1M
Liabilities And Stockholders Equity8.3B11.8B13.4B18.2B22.7B23.9B
Non Current Liabilities Total1.0B1.5B1.5B1.8B1.6B1.7B
Other Current Assets213.5M308.3M545.8M553.5M623.7M654.9M
Other Stockholder Equity7.9B7.9B6.9B7.4B7.4B7.8B
Total Liab2.2B3.1B3.3B4.2B5.1B5.4B
Total Current Assets4.6B7.8B9.0B12.7B14.1B14.9B
Short Term Debt30.3M(275.0M)80.2M89.4M83.7M87.9M
Accounts Payable87.6M155.1M195M303.9M364.9M383.1M
Property Plant And Equipment Gross745.1M958.5M2.3B2.5B2.6B2.8B
Accumulated Other Comprehensive Income(2.0M)(68.5M)15.9M800K(14.3M)(13.6M)
Net Receivables633.5M885.4M1.1B1.4B1.6B1.6B
Common Stock Total Equity2.6M2.6M2.5M2.6M3.0M1.9M
Common Stock2.6M2.6M2.5M2.6M3.0M2.0M
Other Assets1.2B587.0M986.9M1.4B1.6B1.7B
Short Term Investments699.0M670.7M729.9M274.5M849.2M579.6M
Property Plant Equipment833.3M958.5M1.1B1.5B1.7B1.8B
Other Liab275.5M923.4M902.2M685.8M788.7M828.1M
Current Deferred Revenue62.3M191.5M171.7M159.6M170.3M118.8M
Inventory167.5M280.8M353.1M460.6M738.8M775.7M
Net Tangible Assets4.7B7.3B8.7B12.2B14.1B14.8B
Retained Earnings Total Equity(1.9B)858.7M3.2B6.5B7.5B7.9B
Long Term Debt Total583.9M581.6M538.6M539.0M619.9M632.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vertex Stock Analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.